0001209191-19-053941.txt : 20191024
0001209191-19-053941.hdr.sgml : 20191024
20191024192631
ACCESSION NUMBER: 0001209191-19-053941
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191022
FILED AS OF DATE: 20191024
DATE AS OF CHANGE: 20191024
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCGLYNN MARGARET G
CENTRAL INDEX KEY: 0001215126
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 191167099
MAIL ADDRESS:
STREET 1: C/O MERCK & CO INC
STREET 2: ONE MERCK DRIVE PO BOX 100
CITY: WHITEHOUSE STATION
STATE: NJ
ZIP: 08889-0100
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-10-22
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001215126
MCGLYNN MARGARET G
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
1
0
0
0
Common Stock
2019-10-22
4
M
0
20000
72.14
A
24124
D
Common Stock
2019-10-22
4
S
0
20000
190.00
D
4124
D
Stock Option (Right to Buy)
72.14
2019-10-22
4
M
0
20000
0.00
D
2024-05-31
Common Stock
20000
0
D
Transaction made pursuant to Ms. McGlynn's company-approved trading plan under Rule 10b5-1.
Fully vested.
/s/ Omar White, Attorney-in-Fact
2019-10-24